Opleidingen details Cygnea Intermediair B.V.
B-cell symposium (ID nummer: 264068)
Nascholing met (fysieke) bijeenkomst(en)/ accreditatie per bijeenkomst
CategorieGeaccrediteerde puntenAccreditatieperiode
Cursus ZA53-11-2016 t/m 2-11-2017
Als u als professional deze cursus gevolgd heeft dan wordt de presentie ingegeven door de opleider.

With recent advances in oncology and especially in Chronic Lymphocytic Leukemia
(CLL), we are now on the beginning of a new era. Better understanding of the biology of
CLL have led to the rapid development of several diagnostic and therapeutic innovations
and are finding its way into daily clinical practice.
To give an overview of the wealth of new data and to better understand these advances in
oncology, we would like to invite you to join and participate in a dynamic and informative
symposium “Diagnostic & therapeutic innovation in B-cell malignancies”.
Last year, the symposium was focused around novel insights regarding the biology,
the role of several signaling pathways and microenvironmental interactions in B-cell
malignancies. This year, well known international and local experts will present and
discuss the latest developments in both diagnostic as well as therapeutic approaches
in high-risk CLL. The symposium will cover a range of topics, from understanding the
biology of high-risk CLL, to the practical guidance of treatment options in high-risk
CLL, all in order to address the question: “How to identify and treat the high-risk
CLL patient?”
The symposium will be led by chairman Prof. Dr. Arnon Kater, professor of Internal
Medicine, specializing in translational hematology, and chair of the Dutch CLL working
group at the Haemato Oncology Foundation for Adults in the Netherlands (HOVON).
We look forward to welcoming you to what will surely be an informative symposium and
a fantastic learning experience.
“Advances in Oncology”: A series of cross-country collaborative educational symposia to
educate (hemato)-oncologists on recent advances in oncology.

BeroepsgroepBeroepsorganisatie
Accreditatiebureau Verpleegkundig Specialisten RegisterVerpleegkundigen & Verzorgenden Nederland
Nederlandse Internisten Vereniging (NIV)KNMG-GAIA
Nederlandse Vereniging voor Pathologie (NVVP)KNMG-GAIA
Verpleegkundig specialist acute zorg bij somatische aandoeningenVerpleegkundigen & Verzorgenden Nederland
Verpleegkundig specialist chronische zorg bij somatische aandoeningenVerpleegkundigen & Verzorgenden Nederland
1 2
Artsen, verpleegkundigen, verpleegkundig specialisten en ziekenhuisapothekers
Symposium
0
75
To give an overview of the wealth of new data and to better understand the advances in
oncology.
Well known international and local experts will present and discuss the latest developments in both diagnostic as well as therapeutic approaches in high-risk CLL.
The symposium will cover a range of topics, from understanding the biology of high-risk CLL, to the practical guidance of treatment options in high-risk CLL, all in order to address the question: “How to identify and treat the high-risk CLL patient?”
Nee
With recent advances in oncology and especially in Chronic Lymphocytic Leukemia (CLL), we are now on the beginning of a new era. Better understanding of the biology of CLL have led to the rapid development of several diagnostic and therapeutic innovations and are finding its way into daily clinical practice.
To give an overview of the wealth of new data and to better understand these advances in oncology, we would like to invite you to join and participate in a dynamic and informative symposium “Diagnostic & therapeutic innovation in B-cell malignancies”.
Last year, the symposium was focused around novel insights regarding the biology, the role of several signaling pathways and microenvironmental interactions in B-cell malignancies. This year, well known international and local experts will present and discuss the latest developments in both diagnostic as well as therapeutic approaches in high-risk CLL. The symposium will cover a range of topics, from understanding the biology of high-risk CLL, to the practical guidance of treatment options in high-risk CLL, all in order to address the question: “How to identify and treat the high-risk CLL patient?”
The symposium will be led by chairman Prof. Dr. Arnon Kater, professor of Internal Medicine, specializing in translational hematology, and chair of the Dutch CLL working group at the Haemato Oncology Foundation for Adults in the Netherlands (HOVON).
We look forward to welcoming you to what will surely be an informative symposium and a fantastic learning experience.
Prof. Dr. A. Kater, Amsterdam, The Netherlands
Dr. D. Rossi, Bellinzona, Switzerland
Prof. Dr. R. Rosenquist, Uppsala, Sweden
Dr. A. Eijkelenboom, Nijmegen, The Netherlands
Prof. Dr. A. Janssens, Leuven, Belgium
Dr. R. Mous, Utrecht, The Netherlands
Dr. M. van Gelder, Maastricht, The Netherlands
Dr. E.J. de Kruijf, Ede, The Netherlands
Bestand  
uitnodiging_CCL_NL DEF 24 aug.pdf6-9-2016 16:1181 KB
Ja
Tijd9:00 - 16:45
LocatieUtrecht (NL) (Toon kaart)

De mensen van Cygnea zijn sinds 1988 actief in zakelijke evenementen. We ontwikkelen en organiseren de meest uiteenlopende bijeenkomsten en zorgen met de technische en administratieve ondersteuning voor een perfecte uitvoering. Uw doelstellingen vormen onze leidraad. We denken met u mee vanuit onze jarenlange ervaring. Vaak adviseren we u door ons te verplaatsen in de positie van uw deelnemers. Want hun tevredenheid bepaalt uw rendement.

De bijeenkomsten die we organiseren, variëren van congressen, werkconferenties, aandeelhoudersvergaderingen en klantendagen tot seminars, workshops, expert meetings, studiereizen en ronde-tafelbijeenkomsten. We begeleiden zakelijke bijeenkomsten van idee tot uitvoering. Daarnaast worden we ingeschakeld voor één of meer modules:

- ontwikkeling van het concept voor de bijeenkomst
- samenstelling van het programma
- benadering en begeleiding van sprekers, sponsoren en workshopleiders
- voorzitterschap en verslaglegging van ronde-tafelbijeenkomsten
- congressecretariaat

Muntstraat 21
3961 AJ
Wijk bij Duurstede
0182-320126